Cargando…
Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia
Acinetobacter baumannii-induced nosocomial pneumonia has become a serious clinical problem because of high antibiotic resistance rates. Antimicrobial peptides (AMP) are an ideal alternative strategy due to their broad-spectrum of antimicrobial activity and low incidence of bacterial resistance. Howe...
Autores principales: | Jung, Chiau-Jing, Liao, You-Di, Hsu, Chih-Chieh, Huang, Ting-Yu, Chuang, Yu-Chung, Chen, Jeng-Wei, Kuo, Yu-Min, Chia, Jean-San |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016998/ https://www.ncbi.nlm.nih.gov/pubmed/33795739 http://dx.doi.org/10.1038/s41598-021-86844-5 |
Ejemplares similares
-
OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii
por: Lin, Ming-Feng, et al.
Publicado: (2015) -
Computational screening of antimicrobial peptides for Acinetobacter baumannii
por: Majumder, Ayan, et al.
Publicado: (2019) -
Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia
por: Kang, Fang-Yu, et al.
Publicado: (2020) -
Antimicrobial Random Peptide Mixtures Eradicate Acinetobacter baumannii Biofilms and Inhibit Mouse Models of Infection
por: Caraway, Hannah E., et al.
Publicado: (2022) -
Interleukin-1 receptor antagonist gene polymorphism in patients with multidrug-resistant Acinetobacter baumannii-associated pneumonia
por: Hsu, Min-Jer, et al.
Publicado: (2012)